Systems Modeling of Quantitative Kinetic Data Identifies Receptor Tyrosine Kinase-specific Resistance Mechanisms to MAPK Pathway Inhibition in Cancer PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Systems Modeling of Quantitative Kinetic Data Identifies Receptor Tyrosine Kinase-specific Resistance Mechanisms to MAPK Pathway Inhibition in Cancer PDF full book. Access full book title Systems Modeling of Quantitative Kinetic Data Identifies Receptor Tyrosine Kinase-specific Resistance Mechanisms to MAPK Pathway Inhibition in Cancer by Allison Claas. Download full books in PDF and EPUB format.
Author: Allison Claas
Publisher:
ISBN:
Category :
Languages : en
Pages : 156
Get Book Here
Book Description
Targeted cancer therapeutics have seen constraint in clinical efficacy due to resistance. Indicators for resistance may include genetic mutations or protein-level overexpression of targeted or bypass receptor tyrosine kinases (RTKs). While the latter is often attributed to gene amplification, genetic characterization of tumor biopsies has failed to explain substantial proportions of resistance. We hypothesize that post-synthesis mechanisms governing RTK levels may represent underappreciated contributors to drug resistance. We have developed an experimental and computational model for the simultaneous analysis of synthesis and post-synthesis mechanisms contributing to protein level changes. The experimental component quantitatively measures processes operating on multiple time scales in a multi-plexed fashion, with methods generalizable to any membrane bound protein. Parameter distribution estimation by fitting data to an integrative cellular model quantifies native RTK processes and enables the study of treatment induced mechanistic changes. It has been reported that triple negative breast cancer cell lines up-regulate many RTKs in response to Mek inhibition, although reported with conflicting mechanisms. Upon integrated analysis, we find both Axl and Her2 have increased lysate levels after Mek inhibition with 3 Mek inhibitors, Selumetinib, Binimetinib, and PD0325901. Axl changes are attributed to a decrease in proteolytic shedding and protein degradation, and Her2 changes are attributed to decreased synthesis. Met shows a decrease in proteolytic shedding similar to Axl, but compensating synthesis and degradation mechanisms counteract the effect. Contrastingly, Erk inhibition shows minor effects on RTK reprogramming, with Erk dimer inhibitor DEL-22379 exhibiting RTK specific protease effects and highlighting RTK specific outcomes of decreased endocytosis. This quantitative model enables prediction of combination therapies with mechanistic process inhibitors. Our predictions match experimental observations that Axl lysate level increases with Mek inhibition remains unchanged in the presence of transcriptional inhibition, supporting a role for post-synthesis mechanisms. Through additional combination with an Axl inhibitor, we are able to further the anti-proliferative and anti-migratory effect of Mek and transcriptional inhibition in TNBC. This study not only provides a novel and broadly applicable quantitative framework for characterizing RTK level changes, but also emphasizes the RTK, pathway target, and inhibitor variation of RTK reprogramming in drug resistance.
Author: Allison Claas
Publisher:
ISBN:
Category :
Languages : en
Pages : 156
Get Book Here
Book Description
Targeted cancer therapeutics have seen constraint in clinical efficacy due to resistance. Indicators for resistance may include genetic mutations or protein-level overexpression of targeted or bypass receptor tyrosine kinases (RTKs). While the latter is often attributed to gene amplification, genetic characterization of tumor biopsies has failed to explain substantial proportions of resistance. We hypothesize that post-synthesis mechanisms governing RTK levels may represent underappreciated contributors to drug resistance. We have developed an experimental and computational model for the simultaneous analysis of synthesis and post-synthesis mechanisms contributing to protein level changes. The experimental component quantitatively measures processes operating on multiple time scales in a multi-plexed fashion, with methods generalizable to any membrane bound protein. Parameter distribution estimation by fitting data to an integrative cellular model quantifies native RTK processes and enables the study of treatment induced mechanistic changes. It has been reported that triple negative breast cancer cell lines up-regulate many RTKs in response to Mek inhibition, although reported with conflicting mechanisms. Upon integrated analysis, we find both Axl and Her2 have increased lysate levels after Mek inhibition with 3 Mek inhibitors, Selumetinib, Binimetinib, and PD0325901. Axl changes are attributed to a decrease in proteolytic shedding and protein degradation, and Her2 changes are attributed to decreased synthesis. Met shows a decrease in proteolytic shedding similar to Axl, but compensating synthesis and degradation mechanisms counteract the effect. Contrastingly, Erk inhibition shows minor effects on RTK reprogramming, with Erk dimer inhibitor DEL-22379 exhibiting RTK specific protease effects and highlighting RTK specific outcomes of decreased endocytosis. This quantitative model enables prediction of combination therapies with mechanistic process inhibitors. Our predictions match experimental observations that Axl lysate level increases with Mek inhibition remains unchanged in the presence of transcriptional inhibition, supporting a role for post-synthesis mechanisms. Through additional combination with an Axl inhibitor, we are able to further the anti-proliferative and anti-migratory effect of Mek and transcriptional inhibition in TNBC. This study not only provides a novel and broadly applicable quantitative framework for characterizing RTK level changes, but also emphasizes the RTK, pathway target, and inhibitor variation of RTK reprogramming in drug resistance.
Author: Gerard Drewes
Publisher: Humana Press
ISBN: 9781617793639
Category : Science
Languages : en
Pages : 0
Get Book Here
Book Description
The multidisciplinary science of chemical proteomics studies how small molecules of synthetic or natural origin bind to proteins and modulate their function. In Chemical Proteomics: Methods and Protocols, expert researchers in the field provide key techniques to investigate chemical proteomics focusing on analytical strategies, how probes are generated, techniques for the discovery of small molecule targets and the probing of target function, and small molecule ligand and drug discovery. Written in the highly successful Methods in Molecular BiologyTM series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Chemical Proteomics : Methods and Protocols seeks to provide methodologies that will contribute to a wider application of chemical proteomics methods in biochemical and cell biological laboratories.
Author: Joseph Schlessinger
Publisher:
ISBN: 9781936113330
Category : Science
Languages : en
Pages : 478
Get Book Here
Book Description
Receptor tyrosine kinases are a large family of cell-surface receptors that respond to a variety of intercellular signals, including insulin, growth factors such as epidermal growth factor (EGF) and fibroblast growth factor (FGF), and molecules involved in neuronal guidance. Ligand binding stimulates the tyrosine kinase activity of the receptors, leading to recruitment of enzymes and adapter proteins that activate intracellular signaling pathways that control cell proliferation, differentiation, and numerous other biological processes. Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Biology discusses the mechanisms underlying receptor tyrosine kinase signaling, including ligand processing, receptor dimerization, receptor trafficking, and the roles of adapters. The contributors also survey the specific functions of the different subfamilies of receptors and examine their many roles in development and normal physiology. In addition, the authors review the important roles of these proteins in insulin resistance and cancer. This volume is thus a vital reference for cell and developmental biologists as well as those working on cancer biology, diabetes, and obesity.
Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 728
Get Book Here
Book Description
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Author: Sam Thiagalingam
Publisher: Cambridge University Press
ISBN: 0521493390
Category : Mathematics
Languages : en
Pages : 597
Get Book Here
Book Description
An overview of the current systems biology-based knowledge and the experimental approaches for deciphering the biological basis of cancer.
Author: Alan R. Saltiel
Publisher: Springer Science & Business Media
ISBN: 0387722041
Category : Medical
Languages : en
Pages : 223
Get Book Here
Book Description
More than 18 million people in the United States have diabetes mellitus, and about 90% of these have the type 2 form of the disease. This book attempts to dissect the complexity of the molecular mechanisms of insulin action with a special emphasis on those features of the system that are subject to alteration in type 2 diabetes and other insulin resistant states. It explores insulin action at the most basic levels, through complex systems.
Author: Andrea Dunaif
Publisher: Springer Science & Business Media
ISBN: 1597451088
Category : Medical
Languages : en
Pages : 361
Get Book Here
Book Description
This volume includes the latest diagnostic criteria for PCOS and comprises the most up-to-date information about the genetic features and pathogenesis of PCOS. It critically reviews the methodological approaches and the evidence for various PCOS susceptibility genes. The book also discusses additional familial phenotypes of PCOS and their potential genetic basis. All four editors of this title are extremely prominent in the field of PCOS.
Author: Thomas S. Deisboeck
Publisher: CRC Press
ISBN: 1439814422
Category : Mathematics
Languages : en
Pages : 492
Get Book Here
Book Description
Cancer is a complex disease process that spans multiple scales in space and time. Driven by cutting-edge mathematical and computational techniques, in silico biology provides powerful tools to investigate the mechanistic relationships of genes, cells, and tissues. It enables the creation of experimentally testable hypotheses, the integration of dat
Author: Jan B. Vermorken
Publisher: Springer Nature
ISBN: 3031231759
Category : Medical
Languages : en
Pages : 361
Get Book Here
Book Description
This is an open access book. With a wealth of exciting data emerging in this rapidly evolving field this book will review the state-of-the-art knowledge with emphasis on multidisciplinary decision and management of head and neck cancer. The book provides significant detail on a wide range of topics including: the role of new targets for treatment, immunotherapy, resistance mechanisms, standardizing molecular profiling programs, and new methods to guide therapeutic approaches. In addition different disease situations are addressed including different treatment approaches in primary disease and in recurrent and/or metastatic disease as well as new developments in pathology, surgery and reconstruction techniques, new systemic therapies in salivary gland cancer, and supportive care and follow-up. All disciplines involved in the treatment of head & neck cancer are covered with a focus on translation into daily practice. The 8th-THNO is designed for medical oncologists, head and neck surgeons, radiation oncologists, otolaryngologists, and other medical professionals involved in the treatment of patients with head and neck cancer.
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 2160
Get Book Here
Book Description
Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.